
| Salt Composition: | Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg) |
| Manufacturer: | Biomax Biotechnics Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Metmost GV 2mg/500mg/0.3mg Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels. Metmost GV 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Metmost GV 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
What is Metmost GV 2mg/500mg/0.3mg Tablet?
Metmost GV 2mg/500mg/0.3mg Tablet is a combination of three medicines: Glimepiride, Metformin, and Voglibose. This medication is used to treat type 2 diabetes mellitus (DM) in adults, in combination with a proper diet and regular exercise. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin works by reducing glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial glucose levels in the body. This combination is not indicated for the treatment of type 1 DM. Always consult a doctor before starting this medication.
What are the possible side effects of Metmost GV 2mg/500mg/0.3mg Tablet?
Common side effects of Metmost GV 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any unusual symptoms, consult your doctor or pharmacist for advice.
Are there any specific conditions in which Metmost GV 2mg/500mg/0.3mg Tablet should not be taken?
Metmost GV 2mg/500mg/0.3mg Tablet should not be taken by patients with known allergies to any of its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis. Consult your doctor before taking this medication if you have any pre-existing medical conditions.
Is it safe to take alcohol while I am also taking Metmost GV 2mg/500mg/0.3mg Tablet?
No, it is not recommended to consume alcohol while taking Metmost GV 2mg/500mg/0.3mg Tablet. This may increase the risk of hypoglycemia and lactic acidosis. Always consult your doctor or pharmacist for personalized advice on medication and alcohol use.
Can the use of Metmost GV 2mg/500mg/0.3mg Tablet cause hypoglycemia?
Yes, Metmost GV 2mg/500mg/0.3mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is essential to monitor your blood sugar levels regularly and adjust your medication regimen as advised by your doctor. Always keep glucose tablets, honey, or fruit juice with you to treat hypoglycemia.
What are the instructions for the storage and disposal of Metmost GV 2mg/500mg/0.3mg Tablet?
Store Metmost GV 2mg/500mg/0.3mg Tablet in its original packaging, tightly closed, according to the instructions on the packaging or label. Dispose of any unused medication properly, and ensure it is not consumed by pets, children, or other individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Metmost GV 2mg/500mg/0.3mg Tablet is to be taken empty stomach.
Alcohol
It is unsafe to consume alcohol with Metmost GV 2mg/500mg/0.3mg Tablet.
Breastfeed
Metmost GV 2mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Metmost GV 2mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.